MetaADEDB 2.0 @ LMMD
empagliflozin
(OBWASQILIWPZMG-QZMOQZSNSA-N)
Structure
SMILES
OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O
Type(s)
Approved
ATC code(s)
A10BD19; A10BD20; A10BK03
Molecular Formula:
C23H27ClO7
Molecular Weight:
450.909
Log P:
1.6134
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
4
TPSA:
108.61
CAS Number(s):
864070-44-0
Synonym(s)
1.
empagliflozin
2.
1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene
3.
BI 10773
4.
BI-10773
5.
BI10773
6.
Jardiance
External Link(s)
MeSHC570240
PubChem Compound11949646
BindingDB150162
ChEBI82720
CHEMBLCHEMBL2107830
DrugBankDB09038
DrugCentral4830
IUPHAR/BPS Guide to PHARMACOLOGY4754
KEGGdr:D10459
Therapeutic Target DatabaseD0P7PD
D06ALD
ZINC36520252
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diabetic KetoacidosisFAERS: 599
Canada Vigilance: 59
Canada Vigilance
US FAERS
2KetoacidosisFAERS: 230
Canada Vigilance: 3
Canada Vigilance
US FAERS
3Weight decreasedFAERS: 178
Canada Vigilance: 4
Canada Vigilance
US FAERS
4Urinary tract infectionFAERS: 152
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
5Blood glucose increasedFAERS: 145
Canada Vigilance: 11
Canada Vigilance
US FAERS
6DizzinessFAERS: 144
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
7NauseaFAERS: 97
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
8VomitingFAERS: 94
Canada Vigilance: 10
Canada Vigilance
US FAERS
9DehydrationFAERS: 93
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
10MalaiseFAERS: 76
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Drug ineffectiveFAERS: 71
Canada Vigilance: 6
Canada Vigilance
US FAERS
12Euglycaemic diabetic ketoacidosisFAERS: 64
Canada Vigilance: 7
Canada Vigilance
US FAERS
13FatigueFAERS: 57
Canada Vigilance: 2
Canada Vigilance
US FAERS
14PruritusFAERS: 54SIDER
US FAERS
15AstheniaFAERS: 52
Canada Vigilance: 2
Canada Vigilance
US FAERS
16HeadacheFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
17Back PainFAERS: 49US FAERS
18Acute kidney injuryFAERS: 48
Canada Vigilance: 6
Canada Vigilance
US FAERS
19Myocardial InfarctionFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Cerebrovascular accidentFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
21PancreatitisFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
22SepsisFAERS: 43
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Blood glucose abnormalFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
24DysuriaFAERS: 40
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
25Abdominal PainFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
26HypotensionFAERS: 34
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
27ThirstFAERS: 33SIDER
US FAERS
28Blood creatinine increasedFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
29Therapeutic response unexpectedFAERS: 30US FAERS
30Abdominal discomfortFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Peripheral swellingFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
32Blood ketone body increasedFAERS: 27US FAERS
33Metabolic acidosisFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
34PneumoniaFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Feeling abnormalFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
36ConstipationFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
37PainFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
38PolyuriaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
39Blood glucose decreasedFAERS: 24US FAERS
40Urine ketone body presentFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
41AlopeciaFAERS: 22US FAERS
42Chest PainFAERS: 22US FAERS
43NasopharyngitisFAERS: 22US FAERS
44Unevaluable eventFAERS: 22US FAERS
45ArthralgiaFAERS: 20SIDER
US FAERS
46UrticariaFAERS: 19US FAERS
47MyalgiaFAERS: 18US FAERS
48InfectionFAERS: 17
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
49Skin UlcerFAERS: 17US FAERS
50Vulvovaginal pruritusFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
51GangreneFAERS: 16US FAERS
52KetonuriaFAERS: 15US FAERS
53Urine ketone bodyFAERS: 15US FAERS
54Vulvovaginal mycotic infectionFAERS: 15SIDER
US FAERS
55prostatitisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
56AcidosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
57CystitisFAERS: 14SIDER
US FAERS
58Genital infection fungalFAERS: 14SIDER
US FAERS
59NephrolithiasisFAERS: 14US FAERS
60SyncopeFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
61TachycardiaFAERS: 14US FAERS
62TremorFAERS: 14US FAERS
63Urinary IncontinenceFAERS: 14US FAERS
64BalanoposthitisFAERS: 13US FAERS
65Memory impairmentFAERS: 13US FAERS
66AnxietyFAERS: 12US FAERS
67Cerebral InfarctionFAERS: 12US FAERS
68HypersensitivityFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
69SomnolenceFAERS: 12US FAERS
70Urinary RetentionFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
71Blood cholesterol increasedFAERS: 11US FAERS
72Blood triglycerides increasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
73ChromaturiaFAERS: 11US FAERS
74Pancreatic carcinomaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
75PyelonephritisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Atrial FibrillationFAERS: 10US FAERS
77Dry skinFAERS: 10US FAERS
78IncontinenceFAERS: 10US FAERS
79KetosisFAERS: 10US FAERS
80PalpitationsFAERS: 10US FAERS
81Renal painFAERS: 10US FAERS
82Septic ShockFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Blood ketone bodyFAERS: 9US FAERS
84ChillsFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Diabetes mellitus inadequate controlFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
86DisabilityFAERS: 9US FAERS
87InfluenzaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
88Acute myocardial infarctionFAERS: 8US FAERS
89Blood glucose fluctuationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
90Chest discomfortFAERS: 8US FAERS
91DeliriumFAERS: 8US FAERS
92DyspepsiaFAERS: 8US FAERS
93Erectile dysfunctionFAERS: 8US FAERS
94ErythemaFAERS: 8US FAERS
95Medication ErrorFAERS: 8US FAERS
96NocturiaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
97SwellingFAERS: 8US FAERS
98ArthritisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Blood potassium increasedFAERS: 7US FAERS
100Blood urine presentFAERS: 7US FAERS
101CellulitisFAERS: 7US FAERS
102FlatulenceFAERS: 7US FAERS
103Genital infectionFAERS: 7SIDER
US FAERS
104Genital rashFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
105HypophagiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Limb injuryFAERS: 7US FAERS
107Product quality issueFAERS: 7US FAERS
108Vulvovaginal burning sensationFAERS: 7US FAERS
109AngioedemaFAERS: 6US FAERS
110Blood ketone body presentFAERS: 6US FAERS
111BronchitisFAERS: 6US FAERS
112Drug effect incompleteFAERS: 6US FAERS
113General physical health deteriorationFAERS: 6US FAERS
114LethargyFAERS: 6US FAERS
115OsteomyelitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
116PolydipsiaFAERS: 6SIDER
US FAERS
117Pulmonary EmbolismFAERS: 6US FAERS
118Rheumatoid ArthritisFAERS: 6US FAERS
119VertigoFAERS: 6US FAERS
120Visual ImpairmentFAERS: 6US FAERS
121Adverse eventFAERS: 5US FAERS
122AgitationFAERS: 5US FAERS
123BlindnessFAERS: 5US FAERS
124Blood creatine increasedFAERS: 5US FAERS
125Blood urea increasedFAERS: 5US FAERS
126Burning sensationFAERS: 5US FAERS
127Creatinine renal clearance increasedFAERS: 5US FAERS
128Diabetes MellitusFAERS: 5SIDER
US FAERS
129EpistaxisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Extra dose administeredFAERS: 5US FAERS
131Flank PainFAERS: 5US FAERS
132FlushingFAERS: 5US FAERS
133GastroenteritisFAERS: 5US FAERS
134Genital burning sensationFAERS: 5US FAERS
135GoutFAERS: 5US FAERS
136Incorrect dose administeredFAERS: 5US FAERS
137Neck PainFAERS: 5US FAERS
138NoduleFAERS: 5US FAERS
139Oropharyngeal painFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
140Product use in unapproved indicationFAERS: 5US FAERS
141SinusitisFAERS: 5US FAERS
142Therapy cessationFAERS: 5US FAERS
143Urine output increasedFAERS: 5SIDER
US FAERS
144Vulvovaginal discomfortFAERS: 5US FAERS
145Altered state of consciousnessFAERS: 4US FAERS
146AmnesiaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
147Blood GlucoseFAERS: 4US FAERS
148Blood potassium decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Bone painFAERS: 4US FAERS
150Cardiac ArrestFAERS: 4US FAERS
151CholecystitisFAERS: 4US FAERS
152CholelithiasisFAERS: 4US FAERS
153Deep Vein ThrombosisFAERS: 4US FAERS
154Depressed moodFAERS: 4US FAERS
155Diabetic FootFAERS: 4US FAERS
156DiplopiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
157DiscomfortFAERS: 4US FAERS
158DysgeusiaFAERS: 4US FAERS
159DysphoniaFAERS: 4US FAERS
160FractureFAERS: 4US FAERS
161Gastrointestinal infectionFAERS: 4US FAERS
162Genital discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
163HungerFAERS: 4US FAERS
164Lip swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
165No adverse eventFAERS: 4US FAERS
166Oral candidiasisFAERS: 4US FAERS
167OverdoseFAERS: 4US FAERS
168Poor quality sleepFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
169Post procedural complicationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Respiratory tract congestionFAERS: 4US FAERS
171AbscessFAERS: 3US FAERS
172Anaphylactic shockFAERS: 3US FAERS
173Angina PectorisFAERS: 3US FAERS
174Apparent deathFAERS: 3US FAERS
175AsthmaFAERS: 3US FAERS
176Bladder NeoplasmFAERS: 3US FAERS
177Bladder painFAERS: 3SIDER
US FAERS
178Bladder spasmFAERS: 3US FAERS
179Blood triglycerides decreasedFAERS: 3US FAERS
180Coronary Artery DiseaseFAERS: 3US FAERS
181DisorientationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
182Electrolyte imbalanceFAERS: 3US FAERS
183GlycosuriaFAERS: 3US FAERS
184HepatitisFAERS: 3US FAERS
185HyperventilationFAERS: 3US FAERS
186InfarctionFAERS: 3US FAERS
187InflammationFAERS: 3US FAERS
188Intestinal ObstructionFAERS: 3US FAERS
189Joint swellingFAERS: 3US FAERS
190LeukocytosisFAERS: 3US FAERS
191Mental status changesFAERS: 3US FAERS
192MicroalbuminuriaFAERS: 3US FAERS
193Mood swingsFAERS: 3US FAERS
194Musculoskeletal PainFAERS: 3US FAERS
195ObesityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
196OrchitisFAERS: 3US FAERS
197Pancreatic enzymes increasedFAERS: 3US FAERS
198Product use issueFAERS: 3US FAERS
199ProteinuriaFAERS: 3US FAERS
200Renal abscessFAERS: 3US FAERS
201Respiratory FailureFAERS: 3US FAERS
202Secretion dischargeFAERS: 3US FAERS
203Therapy non-responderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
204ThrombosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Tooth ExtractionFAERS: 3US FAERS
206Urine flow decreasedFAERS: 3US FAERS
207Vaginal lesionFAERS: 3US FAERS
208Vulvovaginal drynessFAERS: 3US FAERS
209Vulvovaginal painFAERS: 3US FAERS
210VulvovaginitisFAERS: 3SIDER
US FAERS
211Alanine Aminotransferase IncreasedFAERS: 2US FAERS
212Anal abscessFAERS: 2US FAERS
213AngerFAERS: 2US FAERS
214AnuriaFAERS: 2US FAERS
215AphoniaFAERS: 2US FAERS
216Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
217BedriddenFAERS: 2US FAERS
218Benign Prostatic HyperplasiaFAERS: 2US FAERS
219Bladder discomfortFAERS: 2US FAERS
220Blood alkaline phosphatase increasedFAERS: 2US FAERS
221Blood insulin decreasedFAERS: 2US FAERS
222Blood pH abnormalFAERS: 2US FAERS
223Blood pH decreasedFAERS: 2US FAERS
224Blood sodium decreasedFAERS: 2US FAERS
225Bowel movement irregularityFAERS: 2US FAERS
226CataractFAERS: 2US FAERS
227Cellulitis of male external genital organFAERS: 2US FAERS
228Choking sensationFAERS: 2US FAERS
229Coma acidoticFAERS: 2US FAERS
230DeafnessFAERS: 2US FAERS
231DebridementFAERS: 2US FAERS
232Decreased insulin requirementFAERS: 2US FAERS
233DementiaFAERS: 2US FAERS
234Diabetic metabolic decompensationFAERS: 2US FAERS
235Diabetic ulcerFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
236Drug dispensing errorFAERS: 2US FAERS
237Drug prescribing errorFAERS: 2US FAERS
238Drug screen positiveFAERS: 2US FAERS
239Dry gangreneFAERS: 2US FAERS
240EpididymitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
241EpilepsyFAERS: 2US FAERS
242Escherichia infectionFAERS: 2US FAERS
243Extremity necrosisFAERS: 2US FAERS
244Eye InfectionFAERS: 2US FAERS
245Eye irritationFAERS: 2US FAERS
246FasciitisFAERS: 2US FAERS
247Feeling jitteryFAERS: 2US FAERS
248Food cravingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Fungal test positiveFAERS: 2US FAERS
250Genital HerpesFAERS: 2US FAERS
251Genital painFAERS: 2US FAERS
252GlossitisFAERS: 2US FAERS
253HemiparesisFAERS: 2US FAERS
254HepatosplenomegalyFAERS: 2US FAERS
255HerniaFAERS: 2US FAERS
256HyperpyrexiaFAERS: 2US FAERS
257Hypertensive crisisFAERS: 2US FAERS
258Impaired work abilityFAERS: 2US FAERS
259Inappropriate schedule of drug administrationFAERS: 2US FAERS
260Inappropriate schedule of product administrationFAERS: 2US FAERS
261Inflammatory marker increasedFAERS: 2US FAERS
262Loss of personal independence in daily activitiesFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
263Maternal exposure during pregnancyFAERS: 2US FAERS
264Micturition frequency decreasedFAERS: 2US FAERS
265Muscle tightnessFAERS: 2US FAERS
266Mycoplasma genitalium infectionFAERS: 2US FAERS
267NephritisFAERS: 2US FAERS
268Nephrotic SyndromeFAERS: 2US FAERS
269NervousnessFAERS: 2US FAERS
270Oral painFAERS: 2US FAERS
271ParanoiaFAERS: 2US FAERS
272Penile swellingFAERS: 2US FAERS
273PhimosisFAERS: 2SIDER
US FAERS
274PhotophobiaFAERS: 2US FAERS
275PresyncopeFAERS: 2US FAERS
276PsoriasisFAERS: 2US FAERS
277Pulmonary thrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
278PurulenceFAERS: 2US FAERS
279PyonephrosisFAERS: 2US FAERS
280Relapsing FeverFAERS: 2US FAERS
281Restless Legs SyndromeFAERS: 2US FAERS
282RetchingFAERS: 2US FAERS
283Rheumatic disorderFAERS: 2US FAERS
284ShockFAERS: 2SIDER
US FAERS
285Skin irritationFAERS: 2US FAERS
286SluggishnessFAERS: 2US FAERS
287StarvationFAERS: 2US FAERS
288StressFAERS: 2US FAERS
289Sudden deathFAERS: 2US FAERS
290Suicide attemptFAERS: 2US FAERS
291Therapy changeFAERS: 2US FAERS
292ThrombocytopeniaFAERS: 2US FAERS
293Tinea crurisFAERS: 2US FAERS
294TinnitusFAERS: 2US FAERS
295Tongue discomfortFAERS: 2US FAERS
296Tooth InfectionFAERS: 2US FAERS
297Toxicity to various agentsFAERS: 2US FAERS
298UlcerFAERS: 2US FAERS
299UrethritisFAERS: 2US FAERS
300Urinary tract obstructionFAERS: 2US FAERS
301Urine albumin/creatinine ratio increasedFAERS: 2US FAERS
302Urine alcohol test positiveFAERS: 2US FAERS
303White blood cell count decreasedFAERS: 2US FAERS
304furuncleFAERS: 2US FAERS
305jaundiceFAERS: 2US FAERS
306pH body fluid abnormalFAERS: 2US FAERS
307AbasiaFAERS: 1US FAERS
308Abdominal rigidityFAERS: 1US FAERS
309Accidental overdoseFAERS: 1US FAERS
310AcneFAERS: 1US FAERS
311Acquired phimosisFAERS: 1US FAERS
312AdenocarcinomaFAERS: 1US FAERS
313Albumin globulin ratio increasedFAERS: 1US FAERS
314AlbuminuriaFAERS: 1US FAERS
315Alcohol poisoningFAERS: 1US FAERS
316Ammonia increasedFAERS: 1US FAERS
317AmputationFAERS: 1US FAERS
318Amylase increasedFAERS: 1US FAERS
319AneurysmFAERS: 1US FAERS
320Ankle FractureFAERS: 1US FAERS
321Antipsychotic drug level below therapeuticFAERS: 1US FAERS
322Aortic Valve StenosisFAERS: 1US FAERS
323ApathyFAERS: 1US FAERS
324AphasiaFAERS: 1US FAERS
325AppendicitisFAERS: 1US FAERS
326ArthropathyFAERS: 1US FAERS
327AtaxiaFAERS: 1US FAERS
328Atrial FlutterFAERS: 1US FAERS
329Atrioventricular BlockFAERS: 1US FAERS
330AuraFAERS: 1US FAERS
331Autoimmune PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Autoimmune hepatitisFAERS: 1US FAERS
333Back disorderFAERS: 1US FAERS
334Bacterial prostatitisFAERS: 1US FAERS
335Bacterial pyelonephritisFAERS: 1US FAERS
336Bacterial sepsisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Biopsy bladder abnormalFAERS: 1US FAERS
338Bladder adenocarcinoma stage unspecifiedFAERS: 1US FAERS
339Bladder transitional cell carcinoma recurrentFAERS: 1US FAERS
340Blood bicarbonate abnormalFAERS: 1US FAERS
341Blood calcium abnormalFAERS: 1US FAERS
342Blood cholesterol abnormalFAERS: 1US FAERS
343Blood cholesterolFAERS: 1US FAERS
344Blood creatinine abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
345Blood electrolytes abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
346Blood erythropoietin increasedFAERS: 1US FAERS
347Blood glucose normalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
348Blood immunoglobulin E increasedFAERS: 1US FAERS
349Blood magnesium decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Blood pHFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
351Blood pressure fluctuationFAERS: 1US FAERS
352Blood triglyceridesFAERS: 1US FAERS
353Blood uric acid decreasedFAERS: 1US FAERS
354Blue Toe SyndromeFAERS: 1US FAERS
355BradycardiaFAERS: 1US FAERS
356BradyphreniaFAERS: 1US FAERS
357CachexiaFAERS: 1US FAERS
358Candida test positiveFAERS: 1US FAERS
359CandiduriaFAERS: 1US FAERS
360Carbon dioxide abnormalFAERS: 1US FAERS
361CardiomegalyFAERS: 1US FAERS
362Carpal Tunnel SyndromeFAERS: 1US FAERS
363Cataract operation complicationFAERS: 1US FAERS
364Cerebral disorderFAERS: 1US FAERS
365Cold sweatFAERS: 1US FAERS
366Consciousness fluctuatingFAERS: 1US FAERS
367Contraindicated product administeredFAERS: 1US FAERS
368Contrast media allergyFAERS: 1US FAERS
369CryingFAERS: 1US FAERS
370CystFAERS: 1US FAERS
371Depressed Level of ConsciousnessFAERS: 1US FAERS
372DermatitisFAERS: 1US FAERS
373Device breakageFAERS: 1US FAERS
374Device occlusionFAERS: 1US FAERS
375Device related infectionFAERS: 1US FAERS
376Diabetic foot infectionFAERS: 1US FAERS
377Diet refusalFAERS: 1US FAERS
378Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
379Disease ProgressionFAERS: 1US FAERS
380Disease recurrenceFAERS: 1US FAERS
381DiverticulitisFAERS: 1US FAERS
382Drug administration errorFAERS: 1US FAERS
383Drug effect variableFAERS: 1US FAERS
384Drug effective for unapproved indicationFAERS: 1US FAERS
385Dumping SyndromeFAERS: 1US FAERS
386Duodenal perforationFAERS: 1US FAERS
387DuodenitisFAERS: 1US FAERS
388DysgraphiaFAERS: 1US FAERS
389DysplasiaFAERS: 1US FAERS
390EGFR gene mutationFAERS: 1US FAERS
391Ear congestionFAERS: 1US FAERS
392Ear discomfortFAERS: 1US FAERS
393Early satietyFAERS: 1US FAERS
394EczemaFAERS: 1US FAERS
395Emotional disorderFAERS: 1US FAERS
396Emotional distressFAERS: 1US FAERS
397Emphysematous cystitisFAERS: 1US FAERS
398EndocarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
399EnuresisFAERS: 1US FAERS
400Epigastric discomfortFAERS: 1US FAERS
401ErysipelasFAERS: 1US FAERS
402Escherichia sepsisFAERS: 1US FAERS
403Escherichia test positiveFAERS: 1US FAERS
404Escherichia urinary tract infectionFAERS: 1US FAERS
405Euphoric moodFAERS: 1US FAERS
406ExcoriationFAERS: 1US FAERS
407Eye inflammationFAERS: 1US FAERS
408Facial paralysisFAERS: 1US FAERS
409Fanconi SyndromeFAERS: 1US FAERS
410Female Orgasmic DisorderFAERS: 1US FAERS
411Fibrin D dimer increasedFAERS: 1US FAERS
412Fluid overloadFAERS: 1US FAERS
413FolliculitisFAERS: 1US FAERS
414Food PoisoningFAERS: 1US FAERS
415FormicationFAERS: 1US FAERS
416Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
417GastrectomyFAERS: 1US FAERS
418Gastric DilatationFAERS: 1US FAERS
419Gastric ulcerFAERS: 1US FAERS
420Gastrointestinal PainFAERS: 1US FAERS
421Gastrointestinal carcinomaFAERS: 1US FAERS
422Gastrointestinal inflammationFAERS: 1US FAERS
423General physical condition abnormalFAERS: 1US FAERS
424General physical condition decreasedFAERS: 1US FAERS
425Genital abscessFAERS: 1US FAERS
426Genital erythemaFAERS: 1US FAERS
427Genital swellingFAERS: 1US FAERS
428Genitourinary tract infectionFAERS: 1US FAERS
429GlaucomaFAERS: 1US FAERS
430Glomerular Filtration RateFAERS: 1US FAERS
431Glucose urine absentFAERS: 1US FAERS
432Groin infectionFAERS: 1US FAERS
433Head BangingFAERS: 1US FAERS
434Hepatic EncephalopathyFAERS: 1US FAERS
435Herpes simplex DNA test positiveFAERS: 1US FAERS
436High density lipoprotein increasedFAERS: 1US FAERS
437Hip surgeryFAERS: 1US FAERS
438HostilityFAERS: 1US FAERS
439HyperacusisFAERS: 1US FAERS
440HyperkeratosisFAERS: 1US FAERS
441Hypermobility syndromeFAERS: 1US FAERS
442HyperoxaluriaFAERS: 1US FAERS
443HyperphagiaFAERS: 1US FAERS
444HypoxiaFAERS: 1US FAERS
445HysterectomyFAERS: 1US FAERS
446Impaired driving abilityFAERS: 1US FAERS
447Impaired gastric emptyingFAERS: 1US FAERS
448Impaired quality of lifeFAERS: 1US FAERS
449IndurationFAERS: 1US FAERS
450Intentional product misuseFAERS: 1US FAERS
451Intentional product use issueFAERS: 1US FAERS
452Intermittent ClaudicationFAERS: 1US FAERS
453Intervertebral disc disorderFAERS: 1US FAERS
454Irritable Bowel SyndromeFAERS: 1US FAERS
455Joint injuryFAERS: 1US FAERS
456LacerationFAERS: 1US FAERS
457Ligament ruptureFAERS: 1US FAERS
458Limb discomfortFAERS: 1US FAERS
459Lip and/or oral cavity cancerFAERS: 1US FAERS
460Lipase increasedFAERS: 1US FAERS
461Liver AbscessFAERS: 1US FAERS
462Low density lipoprotein increasedFAERS: 1US FAERS
463Lyme DiseaseFAERS: 1US FAERS
464LymphadenopathyFAERS: 1US FAERS
465LymphomaFAERS: 1US FAERS
466Magnesium DeficiencyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
467Malignant neoplasm progressionFAERS: 1US FAERS
468MarasmusFAERS: 1US FAERS
469Maternal exposure timing unspecifiedFAERS: 1US FAERS
470Mechanical ventilationFAERS: 1US FAERS
471Mental impairmentFAERS: 1US FAERS
472Mesenteric PanniculitisFAERS: 1US FAERS
473Miller Fisher SyndromeFAERS: 1US FAERS
474MonoplegiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
475Mouth swellingFAERS: 1US FAERS
476MultimorbidityFAERS: 1US FAERS
477Muscle FatigueFAERS: 1US FAERS
478Musculoskeletal chest painFAERS: 1US FAERS
479Musculoskeletal stiffnessFAERS: 1US FAERS
480MydriasisFAERS: 1US FAERS
481Myocardial fibrosisFAERS: 1US FAERS
482MyopathyFAERS: 1US FAERS
483NecrosisFAERS: 1US FAERS
484NephrosclerosisFAERS: 1US FAERS
485Nerve injuryFAERS: 1US FAERS
486NeuralgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
487Neuroleptic Malignant SyndromeFAERS: 1US FAERS
488NeutropeniaFAERS: 1US FAERS
489Nitrite urine absentFAERS: 1US FAERS
490Non-cardiac chest painFAERS: 1US FAERS
491Noninfective gingivitisFAERS: 1US FAERS
492Ocular icterusFAERS: 1US FAERS
493Oral infectionFAERS: 1US FAERS
494Oral mucosal eruptionFAERS: 1US FAERS
495Oropharyngeal plaqueFAERS: 1US FAERS
496Orthostatic hypertensionFAERS: 1US FAERS
497PallorFAERS: 1US FAERS
498Pancreatic calcificationFAERS: 1US FAERS
499Panic DisorderFAERS: 1US FAERS
500Pelvic abscessFAERS: 1US FAERS
501Penile InfectionFAERS: 1US FAERS
502Penile burning sensationFAERS: 1US FAERS
503Penile erythemaFAERS: 1US FAERS
504Perineal painFAERS: 1US FAERS
505Peripheral arterial occlusive diseaseFAERS: 1US FAERS
506Peripheral artery occlusionFAERS: 1US FAERS
507Peripheral artery stenosisFAERS: 1US FAERS
508Peripheral venous diseaseFAERS: 1US FAERS
509Pharyngeal swellingFAERS: 1US FAERS
510PharyngitisFAERS: 1US FAERS
511Physical disabilityFAERS: 1US FAERS
512PneumothoraxFAERS: 1US FAERS
513Porphyria non-acuteFAERS: 1US FAERS
514Portal Vein ThrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
515Pre-existing condition improvedFAERS: 1US FAERS
516Premature EjaculationFAERS: 1US FAERS
517Procedural vomitingFAERS: 1US FAERS
518Product administration errorFAERS: 1US FAERS
519Product prescribing errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
520Prostatic painFAERS: 1US FAERS
521Protein urine presentFAERS: 1US FAERS
522Pulmonary FibrosisFAERS: 1US FAERS
523Pulmonary congestionFAERS: 1US FAERS
524PurpuraFAERS: 1US FAERS
525Purulent dischargeFAERS: 1US FAERS
526PyelitisFAERS: 1US FAERS
527Rash erythematousFAERS: 1US FAERS
528RegurgitationFAERS: 1US FAERS
529Renal Cell CarcinomaFAERS: 1US FAERS
530Renal ColicFAERS: 1US FAERS
531Retinal Artery OcclusionFAERS: 1US FAERS
532RhabdomyolysisFAERS: 1US FAERS
533Rhinovirus infectionFAERS: 1US FAERS
534Rocky Mountain Spotted FeverFAERS: 1US FAERS
535RosaceaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
536Rotator cuff syndromeFAERS: 1US FAERS
537SciaticaFAERS: 1US FAERS
538SclerodermaFAERS: 1US FAERS
539Scrotal InfectionFAERS: 1US FAERS
540Scrotal irritationFAERS: 1US FAERS
541Sense of oppressionFAERS: 1US FAERS
542Sexual DysfunctionFAERS: 1US FAERS
543Single functional kidneyFAERS: 1US FAERS
544Sinus TachycardiaFAERS: 1US FAERS
545Skin reactionFAERS: 1US FAERS
546Soft Tissue InfectionFAERS: 1US FAERS
547Soft tissue necrosisFAERS: 1US FAERS
548SplenomegalyFAERS: 1US FAERS
549SpondylitisFAERS: 1US FAERS
550Squamous cell carcinoma of lungFAERS: 1US FAERS
551Staphylococcal abscessFAERS: 1US FAERS
552Staphylococcus test positiveFAERS: 1US FAERS
553Starvation ketoacidosisFAERS: 1US FAERS
554Stasis dermatitisFAERS: 1US FAERS
555Steroid therapyFAERS: 1US FAERS
556Streptococcal urinary tract infectionFAERS: 1US FAERS
557Streptococcus test positiveFAERS: 1US FAERS
558Subcutaneous AbscessFAERS: 1US FAERS
559Superficial vein prominenceFAERS: 1US FAERS
560Symmetrical drug-related intertriginous and flexural exanthemaFAERS: 1US FAERS
561SyndactylyFAERS: 1US FAERS
562Throat cancerFAERS: 1US FAERS
563Throat irritationFAERS: 1US FAERS
564ThyroiditisFAERS: 1US FAERS
565Tooth LossFAERS: 1US FAERS
566ToothacheFAERS: 1US FAERS
567Troponin I increasedFAERS: 1US FAERS
568Ureteric compressionFAERS: 1US FAERS
569Urethral StenosisFAERS: 1US FAERS
570Urinary hesitationFAERS: 1US FAERS
571Urinary strainingFAERS: 1US FAERS
572Urinary tract infection fungalFAERS: 1US FAERS
573Urinary tract inflammationFAERS: 1US FAERS
574Uterine CancerFAERS: 1US FAERS
575Uterine ProlapseFAERS: 1US FAERS
576Vaginal erosionFAERS: 1US FAERS
577Vaginal exfoliationFAERS: 1US FAERS
578Vascular purpuraFAERS: 1US FAERS
579VasculitisFAERS: 1US FAERS
580Venous thrombosis limbFAERS: 1US FAERS
581Vulvovaginal swellingFAERS: 1US FAERS
582Wrong doseFAERS: 1US FAERS
583carbuncleFAERS: 1US FAERS
584colonoscopyFAERS: 1US FAERS
585intensive careFAERS: 1US FAERS
586pH urine abnormalFAERS: 1US FAERS
587Asymptomatic bacteriuriaSIDER
588BalanitisSIDER
589Crystal urine presentCanada Vigilance: 1Canada Vigilance
590Diabetic NephropathySIDER
591DiuresisSIDER
592Feeling ColdCanada Vigilance: 1Canada Vigilance
593Fluid imbalanceCanada Vigilance: 1Canada Vigilance
594Gastric infectionCanada Vigilance: 1Canada Vigilance
595InfestationSIDER
596MalnutritionSIDER
597Musculoskeletal discomfortSIDER
598NeuropathySIDER
599Oropharyngeal candidiasisCanada Vigilance: 1Canada Vigilance
600VulvitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.